New Trends and Hot Spots in the Study of Diabetic Peripheral Neuropathy: A Bibliometric Analysis

Jiajie Li; Jiaqi Wang; Yaping Wang; Xinyi Huai; Guirong Zhang; Zezhu Li; Jiabao Liao; Qin Li; Weibo Wen

doi:10.62177/apjcmr.v1i4.778

Authors

Jiajie Li Yunnan University of Chinese Medicine
Jiaqi Wang East China Normal University
Yaping Wang Yunnan University of Chinese Medicine
Xinyi Huai Yunnan University of Chinese Medicine
Guirong Zhang Yunnan University of Chinese Medicine
Zezhu Li Yunnan University of Chinese Medicine
Jiabao Liao Yunnan University of Chinese Medicine
Qin Li Yunnan University of Chinese Medicine
Weibo Wen Yunnan University of Chinese Medicine

DOI:

https://doi.org/10.62177/apjcmr.v1i4.778

Keywords:

Diabetic Peripheral Neuropathy, Bibliometric Analysis, VOSviewer, CiteSpace, R-bibliometrix

Abstract

Objective: Diabetic Peripheral Neuropathy (DPN) is a common chronic complication of diabetes that currently has no therapeutic recourse. Advanced DPN stages are characterized by severe symptoms that place a huge burden on patients and healthcare systems. To the best of our knowledge, research hotspots within the field of DPN are yet to be visually analyzed, and so is the exploration of developmental dynamics within the same discipline. Methods: Herein, DPN articles published between 2002 and 2022 were retrieved from the Web of Science Core Collection database. Following that, bibliometric analysis was performed on these articles using CiteSpace, VOSviewer, Microsoft Excel, and R-bibliometrix tools. Results: We retrieved 2,761 DPN articles involving 11,605 researchers from 1,140 institutions in 99 countries/regions. The United States was the country/region with the highest number of publications. The most productive author was Malik Rayaz A from the University of Manchester, which was the most productive institution. The most co-cited journals were Diabetes Care, Pain, and Neurology. On the other hand, #0 neuropathic pain, #1 neuropathic pain treatment and #2 peripheral neuropathy were the most clustered keywords in co-cited references. Based on the clustering of keywords, timeline graphs, and citation bursts, "risk", "corneal confocal microscopy" and "systematic review" were identified as the key issues for future DPN research. Conclusion: This article summarizes the current DPN research status and focus areas, reveals the future development trend, and points out potential research directions for DPN scholars.

Downloads

Download data is not yet available.

References

Tampi, R. R. (2023). Diabetes, Cognition, and Mortality. The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry, 31(8), 583–585.

International Diabetes Federation (IDF). (2021). IDF Diabetes Atlas 10th Edition 2021 [Z].

Fralick, M., Jenkins, A. J., Khunti, K., et al. (2022). Global accessibility of therapeutics for diabetes mellitus. Nature Reviews Endocrinology, 18(4), 199–204.

International Diabetes Federation (IDF). (2023). IDF Diabetes Atlas 2022 Reports [Z].

Wang, D., Ye, J., Shi, R., et al. (2022). Dietary protein and amino acid restriction: Roles in metabolic health and aging-related diseases. Free Radical Biology & Medicine, 178, 226–242.

Liu, Y. P., Tian, M. Y., Yang, Y. D., et al. (2022). Schwann cells-derived exosomal miR-21 participates in high glucose regulation of neurite outgrowth. iScience, 25(10), 105141.

Gantner, M. L., Eade, K., Wallace, M., et al. (2019). Serine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy. The New England Journal of Medicine, 381(15), 1422–1433.

Fridman, V., Zarini, S., Sillau, S., et al. (2021). Altered plasma serine and 1-deoxydihydroceramide profiles are associated with diabetic neuropathy in type 2 diabetes and obesity. Journal of Diabetes and Its Complications, 35(4), 107852.

Handzik, M. K., Gengatharan, J. M., Frizzi, K. E., et al. (2023). Insulin-regulated serine and lipid metabolism drive peripheral neuropathy. Nature, 614(7946), 118–124.

Yang, J., Yang, X., Wu, G., et al. (2023). Gut microbiota modulate distal symmetric polyneuropathy in patients with diabetes. Cell Metabolism, 35(9), 1548–1562.e7.

Yang, K., Wang, Y., Li, Y. W., et al. (2022). Progress in the treatment of diabetic peripheral neuropathy. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 148, 112717.

Du, S. H., Zheng, Y. L., Zhang, Y. H., et al. (2022). The Last Decade Publications on Diabetic Peripheral Neuropathic Pain: A Bibliometric Analysis. Frontiers in Molecular Neuroscience, 15, 854000.

Pan, X., Yan, E., Cui, M., et al. (2018). Examining the usage, citation, and diffusion patterns of bibliometric mapping software: A comparative study of three tools. Journal of Informetrics, 12(2), 481–493.

Khalil, G. M., & Gotway Crawford, C. A. (2015). A bibliometric analysis of U.S.-based research on the Behavioral Risk Factor Surveillance System. American Journal of Preventive Medicine, 48(1), 50–57.

Van Eck, N. J., & Waltman, L. (2010). Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics, 84(2), 523–538.

Selvarajah, D., Kar, D., Khunti, K., et al. (2019). Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention. The Lancet Diabetes & Endocrinology, 7(12), 938–948.

Sloan, G., Selvarajah, D., & Tesfaye, S. (2021). Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy. Nature Reviews Endocrinology, 17(7), 400–420.

Pop-Busui, R., Boulton, A. J., Feldman, E. L., et al. (2017). Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care, 40(1), 136–154.

Dworkin, R. H., Corbin, A. E., Young, J. P., Jr., et al. (2003). Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology, 60(8), 1274–1283.

Sabatowski, R., Gálvez, R., Cherry, D. A., et al. (2004). Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain, 109(1–2), 26–35.

Van Seventer, R., Feister, H. A., Young, J. P., Jr., et al. (2006). Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial. Current Medical Research and Opinion, 22(2), 375–384.

Rosenstock, J., Tuchman, M., Lamoreaux, L., et al. (2004). Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain, 110(3), 628–638.

Richter, R. W., Portenoy, R., Sharma, U., et al. (2005). Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. The Journal of Pain, 6(4), 253–260.

Lesser, H., Sharma, U., Lamoreaux, L., et al. (2004). Pregabalin relieves symptoms of painful diabetic peripheral neuropathy: a randomized controlled trial. Neurology, 63(11), 2104–2110.

Tölle, T., Freynhagen, R., Versavel, M., et al. (2008). Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study. European Journal of Pain (London, England), 12(2), 203–213.

Gilron, I., Bailey, J. M., Tu, D., et al. (2005). Morphine, gabapentin, or their combination for neuropathic pain. The New England Journal of Medicine, 352(13), 1324–1334.

Attal, N., Cruccu, G., Haanpää, M., et al. (2006). EFNS guidelines on pharmacological treatment of neuropathic pain. European Journal of Neurology, 13(11), 1153–1169.

Attal, N., Cruccu, G., Baron, R., et al. (2010). EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. European Journal of Neurology, 17(9), 1113–e88.

Feldman, E. L., Callaghan, B. C., Pop-Busui, R., et al. (2019). Diabetic neuropathy. Nature Reviews Disease Primers, 5(1), 41.

Vincent, A. M., Callaghan, B. C., Smith, A. L., et al. (2011). Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nature Reviews Neurology, 7(10), 573–583.

Feldman, E. L., Nave, K. A., Jensen, T. S., et al. (2017). New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain. Neuron, 93(6), 1296–1313.

Cheng, Y., Cao, W., Zhang, J., et al. (2022). Determinants of Diabetic Peripheral Neuropathy and Their Clinical Significance: A Retrospective Cohort Study. Frontiers in Endocrinology, 13, 934020.

Su, J. B., Zhao, L. H., Zhang, X. L., et al. (2018). HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients. Cardiovascular Diabetology, 17(1), 47.

Ban, J., Pan, X., Yang, L., et al. (2023). Correlation Between Fibrinogen/Albumin and Diabetic Peripheral Neuropathy. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 16, 2991–3005.

Ocak, Ö., Silan, F., & Şahin, E. M. (2022). Melatonin receptor gene polymorphisms as a risk factor in patients with diabetic peripheral neuropathy. Diabetes/Metabolism Research and Reviews, 38(8), e3573.

Serra, M. C., Kancherla, V., Khakharia, A., et al. (2020). Long-term metformin treatment and risk of peripheral neuropathy in older Veterans. Diabetes Research and Clinical Practice, 170, 108486.

Yang, R., Yu, H., Wu, J., et al. (2023). Metformin treatment and risk of diabetic peripheral neuropathy in patients with type 2 diabetes mellitus in Beijing, China. Frontiers in Endocrinology, 14, 1082720.

Petropoulos, I. N., Manzoor, T., Morgan, P., et al. (2013). Repeatability of in vivo corneal confocal microscopy to quantify corneal nerve morphology. Cornea, 32(5), e83–e89.

Xiong, Q., Lu, B., Ye, H. Y., et al. (2018). Corneal confocal microscopy as a non-invasive test to assess diabetic peripheral neuropathy. Diabetes Research and Clinical Practice, 136, 85–92.

Pritchard, N., Edwards, K., Russell, A. W., et al. (2015). Corneal confocal microscopy predicts 4-year incident peripheral neuropathy in type 1 diabetes. Diabetes Care, 38(4), 671–675.

Carmichael, J., Fadavi, H., Ishibashi, F., et al. (2022). Implementation of corneal confocal microscopy for screening and early detection of diabetic neuropathy in primary care alongside retinopathy screening: Results from a feasibility study. Frontiers in Endocrinology, 13, 891575.

Salahuddin, T., Petropoulos, I. N., Ferdousi, M., et al. (2021). Artificial Intelligence-Based Classification of Diabetic Peripheral Neuropathy From Corneal Confocal Microscopy Images. Diabetes Care, 44(7), e151–e153.

Preston, F. G., Meng, Y., Burgess, J., et al. (2022). Artificial intelligence utilising corneal confocal microscopy for the diagnosis of peripheral neuropathy in diabetes mellitus and prediabetes. Diabetologia, 65(3), 457–466.

Fleischer, M., Lee, I., Erdlenbruch, F., et al. (2021). Corneal confocal microscopy differentiates inflammatory from diabetic neuropathy. Journal of Neuroinflammation, 18(1), 89.

Gad, H., Petropoulos, I. N., Khan, A., et al. (2022). Corneal confocal microscopy for the diagnosis of diabetic peripheral neuropathy: A systematic review and meta-analysis. Journal of Diabetes Investigation, 13(1), 134–147.

Clair, C., Cohen, M. J., Eichler, F., et al. (2015). The Effect of Cigarette Smoking on Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis. Journal of General Internal Medicine, 30(8), 1193–1203.

Mu, Z. P., Wang, Y. G., Li, C. Q., et al. (2017). Association Between Tumor Necrosis Factor-α and Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes: a Meta-Analysis. Molecular Neurobiology, 54(2), 983–996.

Lv, W. S., Zhao, W. J., Gong, S. L., et al. (2015). Serum 25-hydroxyvitamin D levels and peripheral neuropathy in patients with type 2 diabetes: a systematic review and meta-analysis. Journal of Endocrinological Investigation, 38(5), 513–518.

Wang, F., Zhang, J., Yu, J., et al. (2017). Diagnostic Accuracy of Monofilament Tests for Detecting Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis. Journal of Diabetes Research, 2017, 8787261.

Shabeeb, D., Najafi, M., Hasanzadeh, G., et al. (2018). Electrophysiological measurements of diabetic peripheral neuropathy: A systematic review. Diabetes & Metabolic Syndrome, 12(4), 591–600.

Pratama, S., Lauren, B. C., & Wisnu, W. (2022). The efficacy of vitamin B(12) supplementation for treating vitamin B(12) deficiency and peripheral neuropathy in metformin-treated type 2 diabetes mellitus patients: A systematic review. Diabetes & Metabolic Syndrome, 16(10), 102634.

Fu, Q., Yang, H., Zhang, L., et al. (2020). Traditional Chinese medicine foot bath combined with acupoint massage for the treatment of diabetic peripheral neuropathy: A systematic review and meta-analysis of 31 RCTs. Diabetes/Metabolism Research and Reviews, 36(2), e3218.

Duarte, R. V., Nevitt, S., Copley, S., et al. (2022). Systematic Review and Network Meta-analysis of Neurostimulation for Painful Diabetic Neuropathy. Diabetes Care, 45(10), 2466–2475.

Tatikola, S. P., Natarajan, V., Desai, V. K., et al. (2022). Effect of various exercise protocols on neuropathic pain in individuals with type 2 diabetes with peripheral neuropathy: A systematic review and meta-analysis. Diabetes & Metabolic Syndrome, 16(9), 102603.